BB
SRRK icon

BB Biotech’s Scholar Rock SRRK Stock Holding History

BB Biotech’s Portfolio SRRK Stock Details SRRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$27.8M Buy
1,476,839
+196,861
+15% +$3.47M 0.7% 28
2018
Q4 		$29.4M Buy
1,279,978
+1,090,021
+574% +$24.7M 0.94% 24
2018
Q3 		$4.89M Buy
+189,957
New +$3.49M 0.13% 31

Other funds holding SRRK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BB Biotech's SRRK Position: Q1 2019 in Review

BB Biotech increased its Scholar Rock (SRRK) stake by 15% in Q1 2019, buying an estimated $3.47M and bringing the position to 1,476,839 shares worth $27.8M. The position accounts for 0.7% of the portfolio, ranked #28.

BB Biotech first reported a position in SRRK in Q3 2018 and has held it in 3 quarters since. The position peaked at $29.4M in Q4 2018. 43 funds tracked by Wall St. Rank hold SRRK as of Q1 2019.

  • BB Biotech held 1,476,839 shares of Scholar Rock worth $27.8M as of Q1 2019.
  • BB Biotech bought 196,861 Scholar Rock shares in Q1 2019, an estimated $3.47M.
  • Scholar Rock made up 0.7% of BB Biotech's portfolio in Q1 2019, its #28 holding.
  • BB Biotech first reported a position in Scholar Rock in Q3 2018 and has held it in 3 quarters since.
  • BB Biotech's Scholar Rock position peaked at $29.4M in Q4 2018.
  • 43 funds tracked by Wall St. Rank held Scholar Rock as of Q1 2019.

Based on BB Biotech's 13F filing for Q1 2019, filed 13 May 2019.